How to Choose an OEM Clear Aligner Partner

Start by separating clinical and production responsibilities

A reliable project scope should state who receives the patient records, who prepares the digital setup, who reviews revisions, who gives final professional approval and when manufacturing may begin. Diagnosis, prescription, treatment decisions and final case approval remain with the qualified dental professional responsible for the patient.

This separation matters because treatment-design support and manufacturing are related but different services. A production partner should not treat an unapproved setup as a production instruction. Ask for a documented approval checkpoint and a clear handoff between the design and manufacturing stages.

Six areas to evaluate before appointing a partner

1. Service scope: confirm whether the proposal covers treatment-design support, manufacturing, packaging, logistics or only selected steps.
2. Digital workflow: agree accepted scan and model formats, naming rules, revision handling, approval records and production-file requirements.
3. Quality controls: ask how order identity, approved staging, production status, exceptions and final release are checked and recorded.
4. Materials and specifications: document the material, thickness, trim, packaging and labelling requirements that apply to the agreed program.
5. Communication: define contacts, response expectations, escalation paths and the information required when a case needs clarification.
6. Market responsibilities: allocate regulatory, registration, labelling and market-access obligations between the participating organizations.

Use a pilot before scaling

A controlled pilot helps both parties test the real workflow before committing to a larger rollout. Choose a representative but manageable group of professionally approved cases and track file acceptance, questions, revisions, turnaround assumptions, packaging accuracy and delivery handoff.

The pilot should end with a written review. Record which specifications are final, which steps need adjustment and which service levels are realistic. This is more useful than relying on a generic sample because it tests the actual collaboration process.

Warning signs during evaluation

Be cautious when responsibilities are vague, approval checkpoints are missing, file requirements are undocumented or a supplier makes broad clinical or regulatory promises without defining the applicable market and responsible party. A credible B2B program should be willing to discuss boundaries as carefully as capabilities.

Also check whether sales language matches the written scope. Statements about speed, capacity, customization or market access should be confirmed for the proposed program rather than assumed to apply universally.

Questions for the first partner meeting

• Which parts of the workflow are included and excluded?
• What evidence of professional approval is required before production?
• Which file formats and naming conventions are accepted?
• How are revisions, exceptions and order status communicated?
• Which packaging, labelling and delivery options are feasible?
• What should a pilot measure before the program is scaled?

Frequently Asked Questions

Professional-use note

This article is intended for dental organizations and professional business partners. It describes a general workflow and does not replace patient-specific diagnosis, clinical judgement, professional approval or requirements applicable in a particular market.